Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of cergutuzumab amunaleukin: A phase I study in patients with advanced and/or metastatic solid tumors
Lassen, U., Van Brummelen, E. M. J., Melero, I., Angevin, E., Joensuu, H., Segal, N. H., Mau-Sørensen, M., Steeghs, N., Rodríguez-Ruiz, M. E., Homicsko, K., Tabernero, J., Cañamero, M., Dejardin, D., Habigt, C., Rossmann, E., Guarin, E., Babitzki, G., Baumann, H. E. S., Silva, A. P., … Argilés, G. (2026). Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of cergutuzumab amunaleukin: A phase I study in patients with advanced and/or metastatic solid tumors. ESMO Open, 11(5), 107697. https://doi.org/10.1016/j.esmoop.2026.107697
Deixa un comentari